Initial Treatment for Psoriasis Flare
For a psoriasis flare, the initial treatment should be topical corticosteroids, preferably starting with a moderate potency (Class III) formulation for most body areas, with adjustments based on location and severity. 1
Topical Corticosteroid Therapy
Selection and Application
- Start with moderate potency (Class III) corticosteroids for most body areas
- For thicker plaques or resistant areas: Consider high-potency (Class I-II) corticosteroids like clobetasol propionate 0.05%
- For sensitive areas (face, intertriginous regions, genitals): Use lower potency corticosteroids (Class VI-VII)
- Application frequency: Once daily application is more effective than alternate day application for complete remission 2
Combination Approaches
- Consider combining with topical vitamin D analogs (calcipotriene/calcipotriol) for enhanced efficacy
- Can be applied simultaneously (mixed 1:1) or serially
- After initial control (typically 2 weeks), transition to weekend corticosteroid use and weekday vitamin D analog use 3
- For scalp psoriasis: Use medicated shampoos containing coal tar, salicylic acid, or solutions/foams of corticosteroids 1
Special Considerations
Anatomical Location
- Face and genital regions: Tacrolimus 0.1% ointment is recommended as monotherapy 3
- Scalp: Solutions or foams of corticosteroids are preferred for better penetration
Duration and Monitoring
- Short-term use (2-4 weeks) is recommended for initial control
- Regular clinical review is essential to monitor for adverse effects
- Watch for signs of skin atrophy, telangiectasia, and striae with prolonged use 1
- Avoid unsupervised repeat prescriptions
Potential Adverse Effects
- Local: Burning sensation (most common), itching, irritation, dryness, folliculitis 4
- With prolonged use: Skin atrophy, striae, telangiectasia, hypopigmentation 4
- Systemic (rare with appropriate use): HPA axis suppression, Cushing's syndrome 4
Important Cautions
- Avoid systemic corticosteroids for psoriasis treatment as they may precipitate erythrodermic psoriasis, generalized pustular psoriasis, or unstable psoriasis upon withdrawal 3, 5
- Systemic corticosteroids should only be used in specific circumstances:
- Persistent uncontrollable erythroderma causing metabolic complications
- Generalized pustular psoriasis (von Zumbusch type) if other drugs are contraindicated
- Hyperacute psoriatic polyarthritis threatening irreversible joint damage 3
For Moderate to Severe Disease
If the psoriasis flare is moderate to severe (>3% body surface area) and doesn't respond adequately to topical therapy:
- Consider phototherapy (narrowband UVB) as first-line treatment 1
- For more extensive disease, consider systemic agents:
- Methotrexate (7.5-25 mg weekly)
- Cyclosporine (3-5 mg/kg/day for short courses of 3-4 months)
- Biologics for severe, recalcitrant disease 1
Adjunctive Measures
- Moisturizers to reduce itching and desquamation
- Coal tar preparations (0.5-1.0% crude coal tar in petroleum jelly)
- Dithranol (Anthralin) starting at 0.1-0.25% concentration with short contact therapy (15-45 minutes daily) 1
Remember that proper patient education on application techniques and potential side effects is essential to improve adherence and treatment outcomes.